 MetaClin Research, Inc. is an innovative clinical research organization. We realize that successful clinical campaigns require commitments that far exceed those detailed in contracts. MetaClin is dedicated to adopting the goals, standards, and long-term visions of our sponsors to guide their products through the clinical phases of development. Since our inception in 2000, MetaClin Research, Inc. has quickly achieved a reputation for efficient study start-up, rapid patient enrollment and high quality data. We offer a professional, experienced coordinating staff and highly skilled investigators. Our clinical trial experience consists of Phase I-IV pharmacokinetic and pharmacodynamic studies for both inpatient and outpatient settings, as well as single and multi-site efficacy and safety trials. Our Inpatient Overnight Facility was designed for optimum efficiency, confidentiality and security, offering our subjects and sponsors the privacy and individuality they desire. From small pilot studies to pivotal multi-center trials, the MetaClin team has established an impressive track record. Click here to download a brochure>
News - MetaClin would like to welcome the following NEW Clinical Investigators to our research group.
- Capital Cardiovascular Consultants Research Institute
- Dr. Kevin Spencer and Dr. Anne B. (Barrie) Spencer
|
|
